Marie-Rose B S Crombag

9PUBLICATIONS
15CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 13, 2021
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients.

Leni van Doorn, Marie-Rose B S Crombag, Hánah N Rier

|Nov 17, 2019
Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study.

Marie-Rose B S Crombag, Thomas P C Dorlo, Ellen van der Pan

|Oct 17, 2019
Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?

Marie-Rose B S Crombag, Stijn L W Koolen, Sophie Wijngaard

|Feb 26, 2019
Neutropenia and docetaxel exposure in metastatic castration-resistant prostate cancer patients: A meta-analysis and evaluation of a clinical cohort.

Aurelia H M de Vries Schultink, Marie-Rose B S Crombag, Erik van Werkhoven

|Feb 09, 2019
Age-Associated Hematological Toxicity in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel in Clinical Practice.

Marie-Rose B S Crombag, Aurelia H M de Vries Schultink, Jacobine G C van Doremalen

Pageof 2